Lobbying Relationship

Client

Ferring Pharmaceuticals, Inc.

More records

Lobbying firm

Arnold & Porter Kaye Scholer LLP

More records

  • Issues related to implementation of average sales price reporting requirements.
  • Issues related to patient access.

Duration: to

General Issues: Medicare/Medicaid, Health Issues

Spending: about $80,000 (But it's complicated. Here's why.)

Agencies lobbied since 2019: U.S. Senate, House of Representatives

Related Foreign Entities: Ferring International Center S.A. (SAINT-PREX, SUI); contribution to lobbying: $0; ownership 100%

Bills mentioned

H.R.2113: Prescription Drug STAR Act

Sponsor: Richard E. Neal (D-Mass.)

S.2051: Strengthening Average Sales Price Reporting Act of 2019

Sponsor: Robert Menendez (D-N.J.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

S.2543: Prescription Drug Pricing Reduction Act of 2019

Sponsor: Charles E. Grassley (R-Iowa)

H.R.1425: Patient Protection and Affordable Care Enhancement Act

Sponsor: Angie Craig (D-Minn.)

H.R.133: Consolidated Appropriations Act, 2021

Sponsor: Henry Cuellar (D-Texas)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Kristine Blackwood Deputy Dir. for Cong. Oversight, HHS (2010-15); Chief Counsel, Senate Aging (09-10); Investigative Counsel, House E&C (07-08); Attorney-Advisor, DOJ Leg Affairs (05-07); Healthcare Fraud Coordinator, DOJ (03-05); AUSA, Central District CA (94-03)
Eugenia Edwards Pierson House Energy and Commerce Committee (2001-05)
Pari Mody Intern, HHS Office of General Counsel Public Health (2013)
CJ Mahler Intern, Sen. Corker (2016); Intern, Senate Foreign Relations Committee (2017); Intern, Senate Health, Education, Labor, and Pensions Committee (2018)
Mickayla Stogsdill Intern, Senate Health, Education, Labor, and Pensions Committee (2018)

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page